Wambolt & Associates, LLC Becton Dickinson & CO Transaction History

Wambolt & Associates, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 19, 2021	SELL	$232.09 - $256.88 $307,751 - $340,622	-1,326 Closed	0 $0
Q4 2020 Jan 19, 2021	SELL	$221.92 - $245.94 $3,328 - $3,689	-15 Reduced 1.12%	1,326 $332,000
Q1 2020 May 11, 2020	SELL	$195.69 - $279.01 $23,482 - $33,481	-120 Reduced 8.21%	1,341 $308,000
Q4 2019 Feb 10, 2020	SELL	$236.45 - $266.82 $21,044 - $23,746	-89 Reduced 5.74%	1,461 $397,000
Q1 2019 Apr 11, 2019	BUY	$206.05 - $248.17 $93,340 - $112,421	453 Added 41.29%	1,550 $387,000
Q4 2018 Jan 29, 2019	BUY	$204.73 - $257.93 $224,588 - $282,949	1,097 New	1,097 $247,000

1,734

249M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $69.4B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Wambolt & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Wambolt & Associates, LLC with notifications on news.